$540 Million is the total value of ADAMS STREET PARTNERS LLC's 17 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RMNI | Rimini Street, Inc. | $136,680,000 | -2.8% | 23,565,433 | 0.0% | 25.29% | +17.8% | |
| Vacasa, Inc. | $129,851,000 | +4.9% | 16,527,901 | 0.0% | 24.03% | +27.2% | ||
| PCTY | Paylocity Holding Corporation | $122,063,000 | -12.9% | 593,200 | 0.0% | 22.59% | +5.7% | |
| QTWO | Q2 Holdings, Inc. | $47,937,000 | -22.4% | 777,562 | 0.0% | 8.87% | -5.9% | |
| Couchbase, Inc. | $31,040,000 | -30.2% | 1,781,872 | 0.0% | 5.74% | -15.4% | ||
| FUSN | Fusion Pharmaceuticals, Inc. | $22,905,000 | +86.3% | 2,947,809 | 0.0% | 4.24% | +125.9% | |
| APTX | Aptinyx, Inc. | $12,249,000 | -15.0% | 5,395,996 | 0.0% | 2.27% | +3.1% | |
| CRVS | Corvus Pharmaceuticals, Inc. | $5,373,000 | -31.9% | 3,275,616 | 0.0% | 0.99% | -17.5% | |
| ZETA | Zeta Global Holdings Corp.class a | $1,027,000 | +59.7% | 84,777 | 0.0% | 0.19% | +93.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Paylocity Holding Corporation | 35 | Q3 2023 | 52.0% |
| Q2 Holdings, Inc. (fka CBG Holdings, Inc.) | 35 | Q3 2023 | 36.6% |
| Corvus Pharmaceuticals, Inc. | 31 | Q3 2023 | 13.7% |
| Rimini Street, Inc. | 24 | Q3 2023 | 36.9% |
| Aptinyx, Inc. | 20 | Q1 2023 | 17.5% |
| magicJack VocalTec Ltd.(fka VocalTec Communications Ltd./Ymax Corporation) | 18 | Q4 2018 | 71.4% |
| Fusion Pharmaceuticals, Inc. | 14 | Q3 2023 | 11.4% |
| OncoMed Pharmaceuticals, Inc. | 12 | Q4 2017 | 7.5% |
| Icosavax, Inc. | 9 | Q3 2023 | 11.6% |
| Vacasa, Inc. | 8 | Q3 2023 | 24.0% |
View ADAMS STREET PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aptinyx Inc. | June 27, 2023 | 5,395,996 | 8.0% |
| Fusion Pharmaceuticals Inc. | February 14, 2022 | 2,947,809 | 6.8% |
| Rimini Street, Inc. | February 14, 2022 | 23,659,431 | 27.2% |
| Paylocity Holding Corp | February 14, 2020 | 1,738,428 | 3.2% |
| Aptinyx Inc. | February 13, 2019 | 4,030,628 | 12.0% |
| Q2 Holdings, Inc. | February 13, 2019 | 1,643,275 | 3.8% |
| Corvus Pharmaceuticals, Inc. | March 21, 2018 | 3,275,616 | 15.5% |
| MAGICJACK VOCALTEC LTD | February 12, 2018 | 1,976,861 | 12.3% |
| RIMINI STREET, INC. | October 20, 2017 | 22,783,556 | 38.9% |
| Five9, Inc. | February 13, 2017 | 1,766,470 | 3.0% |
View ADAMS STREET PARTNERS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13D/A | 2023-11-24 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| SC 13D/A | 2023-06-27 |
| SC 13D/A | 2023-06-13 |
| 4 | 2023-06-08 |
| 13F-HR | 2023-05-15 |
View ADAMS STREET PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.